Adeshwar Meditex (BOM:543309) Research & Development: ₹0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543309 Adeshwar Meditex Ltd BOM:543309
63 GF Score
Price ₹16.30
GF Value ₹15.09
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Adeshwar Meditex Research & Development?

Adeshwar Meditex BOM:543309 63 Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:543309 with a GF Score™ of 63/100 and a GF Value™ of ₹15.09 (Fairly Valued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Adeshwar Meditex's Research & Development for the six months ended in Mar. 2026 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Adeshwar Meditex  (BOM:543309) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Adeshwar Meditex Research & Development Related Terms

Adeshwar Meditex Research & Development Historical Data

* Premium members only.

The historical data trend for Adeshwar Meditex's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adeshwar Meditex Research & Development Chart

Adeshwar Meditex Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Adeshwar Meditex Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543309
63GF Score
Adeshwar Meditex Ltd BOM:543309
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adeshwar Meditex Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Adeshwar Meditex (BOM:543309) has a Research & Development of ₹0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Adeshwar Meditex and its competitors.
Is Adeshwar Meditex's Research & Development too high?
Adeshwar Meditex's current Research & Development is ₹0.0 Mil. Overall, Adeshwar Meditex has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adeshwar Meditex's Research & Development compare to ISRG and BDX?
Adeshwar Meditex's Research & Development of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Adeshwar Meditex and its competitors. Adeshwar Meditex's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adeshwar Meditex stock overvalued right now?
Based on GuruFocus' analysis, Adeshwar Meditex (BOM:543309) is currently considered Fairly Valued. The stock's GF Value™ is ₹15.09, compared to a current price of ₹16.30 — trading 8% above its estimated fair value. The current Research & Development is ₹0.0 Mil. Adeshwar Meditex's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Adeshwar Meditex (BOM:543309), the current Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adeshwar Meditex (BOM:543309) Overvalued in 2026?

Based on GuruFocus' analysis, Adeshwar Meditex stock appears to be overvalued. The current stock price of ₹16.30 is trading 8% above its estimated GF Value™ of ₹15.09. GuruFocus considers Adeshwar Meditex to be Fairly Valued.

Key valuation signals for BOM:543309:

  • Research & Development: ₹0.0 Mil
  • GF Value™: ₹15.09 vs. price of ₹16.30 (8% above fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the BOM:543309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adeshwar Meditex Business Description

Address Marol Maroshi Road, Gala 111 Lok Centre, Andheri East, Marol Naka, Mumbai, MH, IND, 400059
Adeshwar Meditex Ltd is engaged in manufacturing surgical dressings and external preparations products such as Sterile surgical wound dressing, Combine dressing, Gauze Dressing and Cotton Products, Medical Bandages and Plaster, Antiseptics / Disinfectants, and others.
63GF Score

Get the complete analysis for BOM:543309

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹16.30
Price
₹15.09
GF Value